Patient organizations: advocating for timely newborn screening & improved quality of life
Authors:
- Diego Fernando Gil CardozoDCDiego Fernando Gil Cardozo
- Lucy McKayLMLucy McKay
- Chiuhui Mary WangCWChiuhui Mary Wang
Open Access
- 15 August 2024
- journal article
- Published by OAE Publishing Inc. in Rare Disease and Orphan Drugs Journal
- Vol. 3 (3)
Abstract
Timely diagnosis is a crucial first step for individuals with rare diseases, significantly affecting their access to treatment, care, and overall well-being. Patient organizations have actively engaged in advocating for Newborn Screening (NBS) to raise awareness about rare diseases. This article examines the efforts of six patient organizations worldwide, each functioning as a national, regional or disease-specific alliance with distinct characteristics. These organizations strongly support NBS due to its proven potential to enable early diagnosis and facilitate timely referral to appropriate treatment and care. They employ several approaches to advocate for the expansion of screening panels or implementation of NBS programs, including education, evidence gathering, and fostering multidisciplinary collaboration. There are opportunities to engage the public and emphasize the value of NBS as a public health service that benefits everyone.Keywords
This publication has 26 references indexed in Scilit:
- Newborn screening in metachromatic leukodystrophy – European consensus-based recommendations on clinical managementEuropean Journal of Paediatric Neurology, 2024
- The modern face of newborn screeningPediatrics & Neonatology, 2022
- View from inside: Patient advocacy in guiding policy development for metabolic disordersJournal of Inherited Metabolic Disease, 2022
- Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to goNeuromuscular Disorders, 2021
- Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet databaseEuropean Journal of Human Genetics, 2019
- Newborn screening in the developing countriesCurrent Opinion in Pediatrics, 2018
- The molecular spectrum and distribution of haemoglobinopathies in Cyprus: a 20-year retrospective studyScientific Reports, 2016
- Current status of newborn screening worldwide: 2015Seminars in Perinatology, 2015
- Forging Stronger Partnerships Between Academic Health Centers and Patient-Driven OrganizationsAcademic Medicine, 2013
- Carrier screening for Beta-thalassaemia: a review of international practiceEuropean Journal of Human Genetics, 2010